Laetitia Marisa

Laetitia Marisa

Auto-generated profile, based on publicly available information

Laetitia Marisa

Ligue Nationale contre le Cancer, Paris, France

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
FPFrancesco Puleo
Francesco Puleo
RNRemy Nicolle
Remy Nicolle
YBYuna Blum
Yuna Blum
Jerome CrosJerome Cros
Jerome Cros
LMLaetitia Marisa
Laetitia Marisa
RMRaphaël Maréchal
Raphaël Maréchal

17 May 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
Gwen LomberkGwen Lomberk
Gwen Lomberk
YBYuna Blum
Yuna Blum
RNRemy Nicolle
Remy Nicolle
ANAsha Nair
Asha Nair
KGKrutika Satish Gaonkar
Krutika Satish Gaonkar
RURaul A. Urrutia
Raul A. Urrutia
Recent studies have offered ample insight into genome-wide expression patterns to define pancreatic ductal adenocarcinoma (PDAC) subtypes, although there remains a lack of knowledge regarding the underlying epigenomics of PDAC. Here we perform multi-parametric integrative analyses of chromatin immunoprecipitation-sequencing (ChIP-seq) on multiple histone modifications, RNA-sequencing (RNA-seq), and DNA methylation to define epigenomic landscapes for PDAC subtypes, which can predict their relative aggressiveness and survival. Moreover, we describe the state of promoters, enhancers, super-enhancers, euchromatic, and heterochromatic regions for each subtype. Further analyses indicate that the distinct epigenomic landscapes are regulated by different membrane-to-nucleus pathways. Inactivation of a basal-specific super-enhancer associated pathway reveals the existence of plasticity between subtypes. Thus, our study provides new insight into the epigenetic landscapes associated with the heterogeneity of PDAC, thereby increasing our mechanistic understanding of this disease, as well as offering potential new markers and therapeutic targets.

25 September 2011 in Nature Medicine
Verified
Journal Article
Closed access
CDCoralie Dorard
Coralie Dorard
ATAurélie de Thonel
Aurélie de Thonel
ACAda Collura
Ada Collura
LMLaetitia Marisa
Laetitia Marisa
MSMagali Svrcek
Magali Svrcek
ADAlex Duval
Alex Duval

19 September 2018 in Oncogenesis
Verified
Journal Article
Open access
PDF file
ABA’dEm Bokhari
A’dEm Bokhari
VJVincent Jonchere
Vincent Jonchere
ALAnaïs Lagrange
Anaïs Lagrange
RBRomane Bertrand
Romane Bertrand
MSMagali Svrcek
Magali Svrcek
ACAda Collura
Ada Collura
Nonsense-mediated mRNA decay (NMD) is responsible for the degradation of mRNAs with a premature termination codon (PTC). The role of this system in cancer is still quite poorly understood. In the present study, we evaluated the functional consequences of NMD activity in a subgroup of colorectal cancers (CRC) characterized by high levels of mRNAs with a PTC due to widespread instability in microsatellite sequences (MSI). In comparison to microsatellite stable (MSS) CRC, MSI CRC expressed increased levels of two critical activators of the NMD system, UPF1/2 and SMG1/6/7. Suppression of NMD activity led to the re-expression of dozens of PTC mRNAs. Amongst these, several encoded mutant proteins with putative deleterious activity against MSI tumorigenesis (e.g., HSP110DE9 chaperone mutant). Inhibition of NMD in vivo using amlexanox reduced MSI tumor growth, but not that of MSS tumors. These results suggest that inhibition of the oncogenic activity of NMD may be an effective strategy for the personalized treatment of MSI CRC.

8 February 2018 in Journal of Experimental Medicine
Verified
Journal Article
Open access
CBCamille Balbinot
Camille Balbinot
Olivier ArmantOlivier Armant
Olivier Armant
NENabila Elarouci
Nabila Elarouci
LMLaetitia Marisa
Laetitia Marisa
EMElisabeth Martin
Elisabeth Martin
IDIsabelle Duluc
Isabelle Duluc
Developmental genes contribute to cancer, as reported for the homeobox gene Cdx2 playing a tumor suppressor role in the gut. In this study, we show that human colon cancers exhibiting the highest reduction in CDX2 expression belong to the serrated subtype with the worst evolution. In mice, mosaic knockout of Cdx2 in the adult intestinal epithelium induces the formation of imperfect gastric-type metaplastic lesions. The metaplastic knockout cells do not spontaneously become tumorigenic. However, they induce profound modifications of the microenvironment that facilitate the tumorigenic evolution of adjacent Cdx2-intact tumor-prone cells at the surface of the lesions through NF-κB activation, induction of inducible nitric oxide synthase, and stochastic loss of function of Apc. This study presents a novel paradigm in that metaplastic cells, generally considered as precancerous, can induce tumorigenesis from neighboring nonmetaplastic cells without themselves becoming cancerous. It unveils the novel property of non–cell-autonomous tumor suppressor gene for the Cdx2 gene in the gut. Graphical Abstract

13 November 2020 in Oncogene
Verified
Journal Article
Closed access
PDF file
MBMarine Beck
Marine Beck
MBMathilde Baranger
Mathilde Baranger
AMAhlam Moufok-Sadoun
Ahlam Moufok-Sadoun
EBEmilie Bersuder
Emilie Bersuder
IHIsabelle Hinkel
Isabelle Hinkel
IGIsabelle Gross
Isabelle Gross